CSF1r inhibitors for use in treating cancer
MYPI2025000985A0Undetermined Publication Date: 2020-06-28DECIPHERA PHARMACEUTICALS LLC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025000985
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-11-11
- Filing Date
- 2019-12-23
- Publication Date
- 2020-06-28
Abstract
Described herein are CSF1R inhibitors for use in methods of treating cancers and other tumors related to the decreased proliferation, the depletion, or the repolarization of tumor-associated macrophages (TAMs) and treatment of associated disorders, including tenosynovial giant cell tumor (TGCT) and diffuse-type tenosynovial giant cell tumor (DTGCT). [Fig. 1]
Need to check novelty before this filing date? Find Prior Art
